Elizabeth Garret-Mayer

Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer

Alberto J. Montero, C. Marcela Díaz‐Montero, Yehuda E. Deutsch et al. · Breast Cancer Research and Treatment · 2011 · 109 citations · Full text

Medicine, Oncology, Pharmacology +14

Immune Chaperone gp96 Drives the Contributions of Macrophages to Inflammatory Colon Tumorigenesis

Crystal Morales, Saleh Rachidi, Shaoli Sun et al. · Cancer Research · 2013 · 61 citations

Medicine, Immunology, Oncology +17

Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia

Judith E. Karp, Tatiana Vener, Mitch Raponi et al. · Blood · 2011 · 26 citations

Medicine, Oncology, Pharmacology +17

Elevated Circulating Myeloid Derived Suppressor Cells (MDSC) Are Associated with Inferior Overall Survival (OS) and Correlate with Circulating Tumor Cells (CTC) in Patients with Metastatic Breast Cancer.

Stewart T. Cole, Alberto J. Montero, Elizabeth Garret-Mayer et al. · Cancer Research · 2009 · 24 citations

Medicine, Immunology, Oncology +16

CD24 blunts oral squamous cancer development and dampens the functional expansion of myeloid-derived suppressor cells

Caroline W. Fugle, Yongliang Zhang, Shaoli Sun et al. · OncoImmunology · 2016 · 17 citations · Full text

Medicine, Immunology, Oncology +15